Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Dermira Inc (DERM)?

Page 1 of 2

The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentive to do the research necessary to beat the market. That’s why we pay close attention to what they think in small cap stocks. In this article, we take a closer look at Dermira Inc (NASDAQ:DERM) from the perspective of those successful funds.

Dermira Inc (NASDAQ:DERM) has seen an increase in activity from the world’s largest hedge funds recently. DERM was in 29 hedge funds’ portfolios at the end of September. There were 24 hedge funds in our database with DERM holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as CVR Energy, Inc. (NYSE:CVI), Western Refining Logistics LP(NYSE:WNRL), and iRobot Corporation (NASDAQ:IRBT) to gather more data points.

Follow Dermira Inc. (NASDAQ:DERM)
Trade (NASDAQ:DERM) Now!

We follow over 700 hedge funds and other institutional investors and by analyzing their quarterly 13F filings, we identify stocks that they are collectively bullish on and develop investment strategies based on this data. One strategy that outperformed the market over the last year involves selecting the 100 best-performing funds and identifying the 30 mid-cap stocks that they are collectively most bullish on. Over the past year, this strategy generated returns of 18%, topping the 8% gain registered by S&P 500 ETFs. We launched this strategy 2.5 years ago and it returned more than 39% since then, vs. 22% gain registered by the S&P 500 ETFs.

Andrey_Popov/Shutterstock.com

Andrey_Popov/Shutterstock.com

With all of this in mind, let’s take a glance at the new action surrounding Dermira Inc (NASDAQ:DERM).

What does the smart money think about Dermira Inc (NASDAQ:DERM)?

At Q3’s end, a total of 29 of the hedge funds tracked by Insider Monkey were bullish on this stock, up 21% from the previous quarter. The graph below displays the number of hedge funds with bullish position in DERM over the last 5 quarters. With hedge funds’ sentiment swirling, there exists an “upper tier” of key hedge fund managers who were boosting their holdings considerably (or already accumulated large positions).

DERM Chart

Of the funds tracked by Insider Monkey, venBio Select Advisor, led by Behzad Aghazadeh, holds the number one position in Dermira Inc (NASDAQ:DERM).The fund reportedly has a $27.3 million position in the stock, comprising 4.8% of its 13F portfolio. The second largest stake is held by Balyasny Asset Management, led by Dmitry Balyasny, which holds a $25.3 million position; 0.1% of its 13F portfolio is allocated to the company. Other members of the smart money with similar optimism encompass Jeffrey Jay and David Kroin’s Great Point Partners, Oleg Nodelman’s EcoR1 Capital and Samuel Isaly’s OrbiMed Advisors. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2